Cited by 199Cancer, Hypoxia, and MetabolismImmune cells in cancerAngiogenesis and VEGF in Cancer

Hypoxia-inducible factors: a central link between inflammation and cancer

Open access
Triner, Daniel, Shah, Yatrik M.·2016·Journal of Clinical Investigation

Abstract

The tumor immune response is in a dynamic balance between antitumor mechanisms, which serve to decrease cancer growth, and the protumor inflammatory response, which increases immune tolerance, cell survival, and proliferation. Hypoxia and expression of HIF-1α and HIF-2α are characteristic features of all solid tumors. HIF signaling serves as a major adaptive mechanism in tumor growth in a hypoxic microenvironment. HIFs represent a critical signaling node in the switch to protumorigenic inflammatory responses through recruitment of protumor immune cells and altered immune cell effector functions to suppress antitumor immune responses and promote tumor growth through direct growth-promoting cytokine production, angiogenesis, and ROS production. Modulating HIF function will be an important mechanism to dampen the tumor-promoting inflammatory response and inhibit cancer growth.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci84430

Cites

149 of 149 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • HIFs play critical roles in cancer progression by activating transcription of genes encoding proteins involved in angiogenesis, glucose metabolism, invasion/metastasis, stem cell specification, protumoral inflammatory responses, and tumor immune evasion.

    “Hypoxia-inducible factors (HIFs) play critical roles in cancer progression by activating the transcription of a large battery of genes encoding proteins that play key roles in angiogenesis, glucose metabolism, invasion/metastasis, stem cell specification, protumoral inflammatory responses, and tumor immune evasion (18, 23–27).”

    From HIF inhibitor 32-134D eradicates murine hepatocellular carcinoma in combination with anti-PD1 therapy (2022) · cites this paper as [26]

    The Introduction describes HIFs as transcription factors and critical drivers of cancer that regulate metabolism, angiogenesis, and invasion/metastasis. The Conclusion and “Hypoxic regulation of tumor immune cell function” also connect HIF signaling to protumor inflammation and suppression of antitumor immunity. Our copy does not support the specific addition of stem cell specification to this list. (LLM, conf=0.87)

    Experimental — accuracy not yet measured
  • This chemokine-driven recruitment can suppress anti-tumor immunity and induce chronic inflammation, which promotes cancer progression by facilitating tumor cell proliferation, survival, angiogenesis, and metastasis.

    “This can result in suppression of the anti-tumor immune response and induce chronic inflammation, which contributes to cancer progression by facilitating tumor cell proliferation, cell survival, angiogenesis and metastasis [68].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 150 references couldn’t be matched to a known paper.

Research works printed but not linked: 2

  1. Rius J, et al. NF-kappaB links innate immu- nity to the hypoxic response through tran- scriptional regulation of HIF-1alpha. Nature. 2008;453(7196):807-811.
  2. Dang EV, et al. Control of T(H)17/T(reg) bal- ance by hypoxia-inducible factor 1. Cell. 2011;146(5):772-784.

Cited by

Sorted by citations

Authors
Triner, D., & Shah, Y. M.
Affiliations
University of Michigan (US)
Corresponding author
Shah, Yatrik M.
Venue
Journal of Clinical Investigation
Published
2016-08-15
Volume
126
Issue
10
Pages
3689-3698
ISSN
  • 0021-9738 (ISSN-L)
  • 1558-8238
OpenAlex
W2514692794
Cited by
199
References
150
Citations by year
2026: 12 · 2025: 20 · 2024: 27 · 2023: 14 · 2022: 24 · 2021: 24 · 2020: 35 · 2019: 15 · 2018: 15 · 2017: 11 · 2016: 2
FWCI
5.97
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • University of Michigan (48109)
  • National Institutes of Health
  • College of Pharmacy, University of Michigan
  • Medical School, University of Michigan
  • National Cancer Institute (R01CA148828)
  • National Institute of General Medical Sciences (T32GM007863)
  • National Institute of Diabetes and Digestive and Kidney Diseases (P30DK034933, R01DK095201, T32DK094775)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
Keywords
hypoxia-inducible factor, HIF-1α, HIF-2α, tumor microenvironment, tumor inflammation, antitumor immunity, tumor hypoxia, angiogenesis, reactive oxygen species, cytokine production, immune cell recruitment, tumor growth
MeSH terms
Endothelial PAS Domain-Containing Protein 1, Animals, Humans, Inflammation, Neoplasms, Neovascularization, Pathologic, Signal Transduction, Cell Hypoxia, Gene Expression Regulation, Neoplastic, Basic Helix-Loop-Helix Proteins, Hypoxia-Inducible Factor 1, Tumor Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review